AGIO (Agios Corp) Earnings growth in current year

AGIO (Agios Corp) - company brandmark

Agios Pharmaceuticals (AGIO) management's strategic pivot toward rare disease therapies has become a key driver, as confirmed by the current YoY EPS growth. The 22.00 metric reflects current profit dynamics. The effectiveness of this course is bolstered by the scaling of R&D projects in hematology and a lean operating model that relies on external contract manufacturing organizations for drug production.

AGIO: Agios Pharmaceuticals Earnings per share growth in current year 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for Agios (AGIO)

Basic company analysis:AGIO - Agios Corp
Finished products of Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals (AGIO) is developing a unique targeted therapy system for rare metabolic pathologies, securing monopoly access to treatment through proprietary developments. The annual growth dynamics of earnings per share reflect the change in net income per share relative to the previous year, allowing investors to assess the actual efficiency of business capitalization and yield volatility through the lens of annual earnings per share growth.

Main competitors

ASND: Net earnings per one share growth for the current year|MDGL (Madrigal Corp) - Earnings growth in current year|Earnings growth in current year Corcept Therapeutics|Earnings growth in current year RYTM|Earnings per share growth in current year AKRO (Akero Therapeutics, Inc.)|Earnings per share growth in current year metsera.com MTSR|MoonLake Corp (MLTX) - Earnings per share growth rate in current year|CRNX - Earnings per share growth in current year|NAMS: Earnings per share growth in current year|SLNO: Earnings growth in current year|FOLD - Expected net earnings per share growth this year|Earnings per share growth in current year 89bio Pharma|Structure Corp (GPCR) - Expected net earnings per share growth this year|Earnings per share growth in current year mimedx.com (MDXG)|Net earnings per share growth this year rezolutebio.com RZLT|Earnings per share growth in current year Lexicon Pharmaceuticals, Inc. LXRX|MBX Bio - Earnings per share growth in current year|ALT: Net earnings per share growth this year|AARD - Earnings growth in current year|SGMT: Earnings growth in current year|Earnings per share growth rate in current year BioAge Labs, Inc. (BIOA)|Earnings per share growth in current year Biomea Fusion Inc|Earnings per share growth this year QNCX (Quince Therapeutics)|Net earnings per share growth this year GUTS (Fractyl Health)|Net earnings per one share growth for the current year VTVT|Agape ATP Corporation - Net earnings per share growth this year|Earnings per share increase in current year PLUR|Synlogic Inc. - Earnings growth in current year|LPCN (Lipocine) - Earnings per share growth this year|MTNB (Matinas BioPharma Holdings Inc.) - Net earnings per share growth this year|SPRB (Spruce Biosciences, Inc.) - Earnings per share growth in current year|GLTO (galecto.com) - Earnings growth in current year|Net earnings per share growth this year carmellrx.com (CTCX)|Earnings per share growth in current year Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Earnings per share increase in current year|radiuspharm.com - Net earnings per share growth this year